Basiliximab reduces acute liver allograft rejection in pediatric patients

Transplant Proc. 2002 Sep;34(6):2374-5. doi: 10.1016/s0041-1345(02)03276-1.
No abstract available

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal / therapeutic use*
  • Basiliximab
  • Child
  • Child, Preschool
  • Cyclosporine / therapeutic use
  • Female
  • Follow-Up Studies
  • Graft Rejection / prevention & control*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Infant
  • Liver Diseases / surgery
  • Liver Transplantation / immunology*
  • Male
  • Recombinant Fusion Proteins*
  • Retrospective Studies
  • Tacrolimus / therapeutic use
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Recombinant Fusion Proteins
  • Cyclosporine
  • Basiliximab
  • Tacrolimus